• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Penumbra Inc (NY: PEN )

    236.22 -5.85 (-2.42%)
    Official Closing Price Updated: 7:00 PM EST, Nov 12, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Penumbra Inc

    < Previous 1 2 3 4 5 6 Next >
    Penumbra's Return on Invested Capital Insights
    Benzinga Pro data, Penumbra (NYSE:PEN) reported Q4 sales of $204.01 million. Earnings fell to a loss of $24.63 million, resulting in a 406.72% decrease from last quarter. In Q3,... 
    Via Benzinga
    Recap: Penumbra Q4 Earnings
    Penumbra (NYSE:PEN) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Penumbra... 
    Via Benzinga
    Earnings Scheduled For February 22, 2022
    Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu... 
    Via Benzinga
    Earnings Outlook For Penumbra
    Penumbra (NYSE:PEN) is set to give its latest quarterly earnings report on Tuesday, 2022-02-22. Here's what investors need to know before the announcement. Analysts estimate that... 
    Via Benzinga
    Penumbra Weighs Combination With Shockwave Medical: Bloomberg
    Penumbra Inc (NYSE: PEN) is exploring a potential deal with Shockwave Medical Inc (NASDAQ: SWAV), Bloomberg reported citing people with knowledge of the... 
    Via Benzinga
    CEO Of Penumbra Trades $3.9M In Company Stock
    Adam Elsesser, CEO at Penumbra (NYSE:PEN), made a large buy and sell of company shares on November 11, according to a new SEC filing. What Happened: A Form 4 filing from the U.S.... 
    Via Benzinga
    Topics Regulatory Compliance
    Exposures Legal Regulatory
    Penumbra's Thrombectomy System Shows Safety, Clinical Benefit
    Penumbra Inc (NYSE: PEN) announced that the CHEETAH clinical study of its Indigo System CAT RX Catheter met the primary endpoint. As part of the Indigo Aspiration... 
    Via Benzinga
    Penumbra: Q2 Earnings Insights
    Shares of Penumbra (NYSE:PEN) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 170.00% over the past year to $0.... 
    Via Benzinga
    The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
    Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
    Via Benzinga
    Exposures Product Safety
    The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
    Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front... 
    Via Benzinga
    New Data Demonstrates Safety and Performance of Continuous Aspiration Thrombectomy with Penumbra’s Indigo® System CAT™ RX Catheter in High-Risk Patients with Acute Coronary Syndrome
    From Penumbra, Inc.
    Via Business Wire
    Penumbra, Inc (PEN) Q3 2021 Earnings Call Transcript
    PEN earnings call for the period ending September 30, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
    Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics... 
    Via Benzinga
    Topics Retirement
    Exposures Pension
    Notable Penumbra Insider Trades $3.8M In Company Stock
    Adam Elsesser, CEO And President at Penumbra (NYSE:PEN), made a large buy and sell of company shares on October 11, according to a new SEC filing. What Happened: A Form 4 filing... 
    Via Benzinga
    Topics Regulatory Compliance
    Exposures Legal Regulatory
    Earnings Scheduled For November 3, 2021
    Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.... 
    Via Benzinga
    The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
    Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
    Via Benzinga
    CEO And President Of Penumbra Trades $4.18 Million In Company Stock
    Adam Elsesser, CEO And President at Penumbra (NYSE:PEN), made a large buy and sell of company shares on September 13, according to a new SEC filing. What Happened: A Form 4 filing... 
    Via Benzinga
    Topics Regulatory Compliance
    Exposures Legal Regulatory
    Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2021
    Upgrades For Signet Jewelers Ltd (NYSE: 
    Via Benzinga
    Penumbra Stock Registers A Healthy RS Rating
    Penumbra shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 81. 
    Via Investor's Business Daily
    EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Penumbra, Inc. Investors With Losses to Inquire About Class Action Investigation – PEN
    From The Rosen Law Firm, P.A.
    Via Business Wire
    Penumbra Q2 Earnings Beat Estimates; Raises FY21 Sales Outlook
    Penumbra Inc (NYSE: PEN) reported Q2 sales of $184.3 million, an increase of 75.3% Y/Y, or 72.7% on a constant currency basis, beating the consensus of $170.76 million... 
    Via Benzinga
    Topics Earnings
    Exposures Financial
    Penumbra Introduces REAL® i-Series™, Expanding REAL Immersive System to Support Broad Range of Care Providers and Mental Health Professionals
    From Penumbra, Inc.
    Via Business Wire
    Penumbra, inc (PEN) Q2 2021 Earnings Call Transcript
    PEN earnings call for the period ending June 30, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Penumbra Receives FDA Clearance for RED 62 Reperfusion Catheter, Enabling Physicians to Address Broad Range of Stroke Patients
    From Penumbra, Inc.
    Via Business Wire
    Earnings Scheduled For August 9, 2021
    Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For June 4, 2021
    Upgrades According to Argus Research, the prior rating for Diageo PLC (NYSE:DEO) was changed from Hold to Buy. The current stock performance of Diageo shows a 52-week-high... 
    Via Benzinga
    NYSE: PEN Long Term Investor Notice: Investigation of Potential Wrongdoing at Penumbra, Inc.
    San Diego, CA -- (SBWIRE) -- 05/10/2021 -- An investigation on behalf of current long term investors in Penumbra, Inc. (NYSE: PEN) shares over possible breaches of fiduciary duty by certain officers... 
    Via SBWire
    Topics Death Lawsuit
    Exposures Death Financial Legal
    Penumbra Inc (PEN) Q1 2021 Earnings Call Transcript
    PEN earnings call for the period ending March 31, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)... 
    Via Benzinga
    Exposures Product Safety
    Stocks That Hit 52-Week Highs On Wednesday
    Wednesday's morning session saw 275 companies set new 52-week highs. Noteworthy Mentions: Home Depot (NYSE:HD) was the largest firm on a market cap basis to set... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.